Finger Hardness Measure in Scleroderma

This study has been completed.

Sponsor:

Information provided by:

Mayo Clinic

ClinicalTrials.gov Identifier:

NCT01111786

First received: April 5, 2010

Last updated: June 24, 2014

Last verified: June 2014

History of Changes

Purpose

Thirty subjects with systemic sclerosis and 30 age and sex matched controls without any known condition that should cause increased skin hardness in the fingers with undergo examination by manual palpation and durometer measured hardness of their digital tuft skin by 2 observers on 2 separate occasions. There will be 1 hour between individual observer's scorings. Observers will be blinded from the observer's scores and from their previous scores. Results will be tabulated and compared for manual scores versus durometer measurements, intra-observer scores by both methods and inter-observer scores by both methods.

Condition
Scleroderma


Study Type:	Observational
Study Design:	Observational Model: Case Control Time Perspective: Cross-Sectional
Official Title:	Durometer Skin Assessment in Scleroderma: a Study to Validate This New Tool in the Digital Tufts

Resource links provided by NLM:

Genetics Home Reference related topics: systemic scleroderma

MedlinePlus related topics: Scleroderma

Genetic and Rare Diseases Information Center resources: Systemic Scleroderma Localized Scleroderma

U.S. FDA Resources

Further study details as provided by Mayo Clinic:

Primary Outcome Measures:

Fingertip hardness in patients with scleroderma and controls: comparing manual assessment(scale0 - 3) with durometer assessment(scale 0- 100). [ Time Frame: 1 year ]
Two investigators will compare data from 30 patients with scleroderma and 30 control patients without fingertip inflammation or tightness twice using durometer readings to those done by manual palpation.


Enrollment:	60
Study Start Date:	April 2010
Study Completion Date:	January 2013
Primary Completion Date:	January 2013 (Final data collection date for primary outcome measure)

Detailed Description:

It is pretty straightforward. We will measure and record the hardness of the digital tufts on ten digits by palpation and the hardness in the same area by using a durometer. We will repeat this one hour later. Scores will be compared as a measure of how consistent and precise they are.

Eligibility


Ages Eligible for Study:	18 Years and older (Adult, Senior)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	Yes
Sampling Method:	Non-Probability Sample

Study Population

Scleroderma and controls without tight skin attending our rheumatology clinic for a regularly schedualled visit

Criteria

Inclusion Criteria:

Scleroderm
Rheumatologic condition not effecting the skin tightness

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01111786

Locations


United States, Minnesota
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905

Sponsors and Collaborators

Mayo Clinic

Investigators


Principal Investigator:	Thomas Osborn, MD	Mayo Clinic

More Information


Responsible Party:	Thomas Osborn, MD, Mayo Clinic
ClinicalTrials.gov Identifier:	NCT01111786 History of Changes
Other Study ID Numbers:	09-007486
Study First Received:	April 5, 2010
Last Updated:	June 24, 2014

Keywords provided by Mayo Clinic:


scleroderma skin tightness durometer

Additional relevant MeSH terms:


Scleroderma, Systemic Scleroderma, Diffuse Scleroderma, Localized Connective Tissue Diseases Skin Diseases

ClinicalTrials.gov processed this record on August 16, 2017

To Top